Reviewing a Research Study in the Biomedical Domain Series – General Administrative Considerations (Part 1 of 4) Institution License

$30.00

Webinar Objectives:

  • To provide criteria for the review of the Administrative Components of a biomedical research including: Sign-offs and Attestations, Conflict of Interest Review and Management, Documentation Required for Appropriate Review, Adequacy of Resources to conduct the research, study type classification and clinical trial registration; and to address the application of appropriate ethical principles and guidelines, and regulatory criteria for the review and approval of the administrative aspects of the research.

Duration: 1 hour.
Date & Time: March 22nd, 2021
4:30 pm EST

Categories: ,

Larissa Potanina has  a Medical Degree from Novosibirsk State Medical University, Russia and completed a Clinical Research Post-Diploma Program at Humber College Institute of Technology and Advanced Learning in Toronto. Larissa has over 17 years of research ethics experience. She works as a Research Ethics Coordinator at Research Ethics Board (REB) at  the University of Health Network in Toronto supporting the Oncology REB Members.  Larissa  promotes participants’ rights to receive information about research in language suitable for lay individuals, especially, when it involves participation in clinical trials.  Her main area of expertise involves research in oncology, research involving the use of biospecimens and health data.  Larissa has co-authored peer-review publications in oncology and consent which includes:

Blanchette, P., Spreafico, A., Miller, F., Chan, K., Bytautas, J., Kang, S., Bedard, P., Eisen, A., Potanina, L., Holland, J., Kamel‐Reid, S., McPherson, J., Razak, A., & Siu, L. (2014). Genomic testing in cancer: Patient knowledge, attitudes, and expectations. Cancer, 120(19), 3066–3073. https://doi.org/10.1002/cncr.28807

Y. Cheung, G. R. Pond, R. J. Heslegrave, L. Potanina, and L. L. Siu. The quality of informed consent forms for oncology clinical trials. Journal of Clinical Oncology 2008 26:15_suppl, 6544-6544